Revenue, last quarter
$142.4M
+2.7% vs same quarter last year
Net income
$6M
+89.8% vs same quarter last year
EPS, diluted
$0.08
+60% vs same quarter last year
Operating cash flow
$20.7M
−31.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $568.1M | $22.7M |
| FY24 | $573.3M | −$36.1M |
| FY23 | $512.3M | −$156.2M |
| FY22 | $512.1M | −$158.7M |
| FY21 | $430.9M | - |
| FY20 | $321.2M | $16.4M |
| FY19 | $340.1M | $6.9M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 68.3% | 9.5% | 4% |
| FY24 | 67.7% | −2.7% | −6.3% |
| FY23 | 64.1% | −16% | −30.5% |
| FY22 | 64.6% | −32.7% | −31% |
| FY21 | 70.3% | 2.8% | - |
| FY20 | 72.7% | 6.6% | 5.1% |
| FY19 | 73.3% | 9.2% | 2% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $72.1M |
| FY24 | $37.8M |
| FY23 | $8M |
| FY22 | −$15M |
| FY21 | $9.5M |
| FY20 | $55.2M |
| FY19 | $38.4M |
- Bioventus
- Healthcare median
Show the numbers
| Year | Bioventus | Healthcare median |
|---|---|---|
| FY25 | 4% | −30.6% |
| FY24 | −6.3% | −47% |
| FY23 | −30.5% | −58% |
| FY22 | −31% | −80.4% |
| FY21 | - | −71.8% |
| FY20 | 5.1% | −62.2% |
| FY19 | 2% | −46.2% |